810 Bn dollars. A lot of money, and the estimated spend by self-insured employers on company healthcare benefits in 2012. Healthcare is now one of the top three costs for these companies (1). Artemis is a start-up in NYC that […]
IMS Health’s products and services were used by pharmaceutical companies to develop commercialization plans, more recently IMS Health has expanded their focus –going beyond analyzing sales trends to improving patient outcomes and effectiveness data.
Traditional data analysis relies on statistics. Ayasdi offers data analysis based on topology with applications ranging from disease research to investing to fraud detection.
Optum Health helping to improve the healthcare system by developing industry-leading data analytics software.
CrowdMed aims to help those who suspect they have a rare disease, perhaps were misdiagnosed, or simply want a second opinion provide the story of their health problem to a community of experts.
DLife is a social network of sorts connecting diabetes patients with one another to share knowledge and information about managing the disease – but does sharing medical advice go too far?
Introducing data collection through emerging technologies to innovate in the heavily regulated space of insurance companies
A new startup, CrowdMed, seeks to bring the wisdom of crowds to the patient by helping to solve the world’s most difficult, rare, and complex chronic medical cases through online communication, collaboration, and brainstorming.
One of Europe’s largest private healthcare providers wins in the digital space, offering seamless health management to their patients and vast savings to themselves
COGITO – transforming behavior into digital information
